Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Dental Anesthesia Market

ID: MRFR/HC/42987-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
South Korea Dental Anesthesia Market Size, Growth Research Report By Product Type (lidocaine, mepivacaine, prilocaine, bupivacaine 0.5% with epinephrine1:200,000, articaine, others), By Mode of Administration (maxillary, mandibular, others), By Technique (local infiltration, field block, nerve block), By Duration of Action (short, medium, long), By End User (hospital clinics, clinics, other) - Competitor Industry Analysis and Trends Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Product Type (USD Million)
      1. 4.1.1 Lidocaine
      2. 4.1.2 Mepivacaine
      3. 4.1.3 Prilocaine
      4. 4.1.4 Bupivacaine 0.5% with epinephrine 1:200,000
      5. 4.1.5 Articaine
      6. 4.1.6 Others
    2. 4.2 Medical Device, BY Mode of Administration (USD Million)
      1. 4.2.1 Maxillary
      2. 4.2.2 Mandibular
      3. 4.2.3 Others
    3. 4.3 Medical Device, BY Technique (USD Million)
      1. 4.3.1 Local Infiltration
      2. 4.3.2 Field Block
      3. 4.3.3 Nerve Block
    4. 4.4 Medical Device, BY Duration of Action (USD Million)
      1. 4.4.1 Short
      2. 4.4.2 Medium
      3. 4.4.3 Long
    5. 4.5 Medical Device, BY End User (USD Million)
      1. 4.5.1 Hospital Clinics
      2. 4.5.2 Clinics
      3. 4.5.3 Other
    6. 4.6 Medical Device, BY Distribution Channel (USD Million)
      1. 4.6.1 Pharmacies And Drug Stores
      2. 4.6.2 E-Commerce
      3. 4.6.3 Other
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Dentsply Sirona (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Henry Schein (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Patterson Companies (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Septodont (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Heraeus Kulzer (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 3M (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Kavo Kerr (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 DentalEZ (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY MODE OF ADMINISTRATION
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
    5. 6.5 SOUTH KOREA MARKET ANALYSIS BY DURATION OF ACTION
    6. 6.6 SOUTH KOREA MARKET ANALYSIS BY END USER
    7. 6.7 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    8. 6.8 KEY BUYING CRITERIA OF MEDICAL DEVICE
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF MEDICAL DEVICE
    11. 6.11 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    13. 6.13 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    14. 6.14 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY TECHNIQUE, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY TECHNIQUE, 2024 TO 2035 (USD Million)
    20. 6.20 MEDICAL DEVICE, BY DURATION OF ACTION, 2024 (% SHARE)
    21. 6.21 MEDICAL DEVICE, BY DURATION OF ACTION, 2024 TO 2035 (USD Million)
    22. 6.22 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    23. 6.23 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    24. 6.24 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    25. 6.25 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Million)
      3. 7.2.3 BY TECHNIQUE, 2025-2035 (USD Million)
      4. 7.2.4 BY DURATION OF ACTION, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
      6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea Medical Device Market Segmentation

Medical Device By Product Type (USD Million, 2025-2035)

  • Lidocaine
  • Mepivacaine
  • Prilocaine
  • Bupivacaine 0.5% with epinephrine 1:200,000
  • Articaine
  • Others

Medical Device By Mode of Administration (USD Million, 2025-2035)

  • Maxillary
  • Mandibular
  • Others

Medical Device By Technique (USD Million, 2025-2035)

  • Local Infiltration
  • Field Block
  • Nerve Block

Medical Device By Duration of Action (USD Million, 2025-2035)

  • Short
  • Medium
  • Long

Medical Device By End User (USD Million, 2025-2035)

  • Hospital Clinics
  • Clinics
  • Other

Medical Device By Distribution Channel (USD Million, 2025-2035)

  • Pharmacies And Drug Stores
  • E-Commerce
  • Other